C/O DENNIS M. LANFEAR, REDWOOD CITY, CA
2026 Annual Meeting of Stockholders Voting Results - Coherus Oncology, Inc.
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Financial Results, Press Release
Coherus Oncology Enters Underwriting Agreement for 28.6 Million Shares
Other Events
Coherus Oncology Files Prospectus Supplement for $64.88M Common Stock Offering
Investor Presentation
FY 2025
Q3
Q2
Q1
FY 2024
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
SC TO-I
Additional Proxy Materials
PRE 14A
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
PREM14A
Submission Upload
Correspondence